OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 44 filers reported holding OYSTER PT PHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 3.6%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $89,204 | -89.0% | 7,986 | -94.5% | 0.00% | – |
| Q3 2022 | $812,000 | +30.3% | 144,528 | +0.3% | 0.00% | – |
| Q2 2022 | $623,000 | -48.9% | 144,051 | +37.5% | 0.00% | – |
| Q1 2022 | $1,219,000 | -8.0% | 104,749 | +44.4% | 0.00% | – |
| Q4 2021 | $1,325,000 | -5.0% | 72,543 | -38.4% | 0.00% | – |
| Q3 2021 | $1,395,000 | +210.0% | 117,728 | +350.0% | 0.00% | – |
| Q2 2021 | $450,000 | -43.3% | 26,162 | -39.7% | 0.00% | – |
| Q1 2021 | $793,000 | -47.9% | 43,373 | -46.4% | 0.00% | – |
| Q4 2020 | $1,522,000 | +21.5% | 80,896 | +36.4% | 0.00% | – |
| Q3 2020 | $1,253,000 | +20.4% | 59,309 | +64.6% | 0.00% | – |
| Q2 2020 | $1,041,000 | +6840.0% | 36,034 | +8183.7% | 0.00% | – |
| Q1 2020 | $15,000 | -91.9% | 435 | -94.2% | 0.00% | – |
| Q4 2019 | $185,000 | – | 7,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $50,554,000 | 15.36% |
| KPCB XIV Associates, LLC | 367,987 | $6,719,000 | 4.17% |
| NEA Management Company, LLC | 5,925,287 | $108,196,000 | 2.19% |
| Paradigm Biocapital Advisors LP | 304,238 | $5,555,000 | 1.59% |
| Sio Capital Management, LLC | 181,857 | $3,321,000 | 1.00% |
| COWEN AND COMPANY, LLC | 509,794 | $9,309,000 | 0.84% |
| RTW INVESTMENTS, LP | 2,058,504 | $37,588,000 | 0.55% |
| ACT CAPITAL MANAGEMENT, LLC | 13,500 | $247,000 | 0.18% |
| COOPER CREEK PARTNERS MANAGEMENT LLC | 79,510 | $1,452,000 | 0.17% |
| Point72 Asset Management, L.P. | 2,101,441 | $38,372,000 | 0.15% |